These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8487059)

  • 1. Placebo-blinded study of morphine sulfate sustained-release tablets and immediate-release morphine sulfate solution in outpatients with chronic pain due to advanced cancer.
    Finn JW; Walsh TD; MacDonald N; Bruera E; Krebs LU; Shepard KV
    J Clin Oncol; 1993 May; 11(5):967-72. PubMed ID: 8487059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A controlled study of sustained-release morphine sulfate tablets in chronic pain from advanced cancer.
    Walsh TD; MacDonald N; Bruera E; Shepard KV; Michaud M; Zanes R
    Am J Clin Oncol; 1992 Jun; 15(3):268-72. PubMed ID: 1590284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, double-blind, multi-site, crossover, placebo-controlled equivalence study of morning versus evening once-daily sustained-release morphine sulfate in people with pain from advanced cancer.
    Currow DC; Plummer JL; Cooney NJ; Gorman D; Glare PA
    J Pain Symptom Manage; 2007 Jul; 34(1):17-23. PubMed ID: 17601560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical efficacy and safety of a novel controlled-release morphine suppository and subcutaneous morphine in cancer pain: a randomized evaluation.
    Bruera E; Fainsinger R; Spachynski K; Babul N; Harsanyi Z; Darke AC
    J Clin Oncol; 1995 Jun; 13(6):1520-7. PubMed ID: 7751901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analgesic response to single and multiple doses of controlled-release morphine tablets and morphine oral solution in cancer patients.
    Goughnour BR; Arkinstall WW; Stewart JH
    Cancer; 1989 Jun; 63(11 Suppl):2294-7. PubMed ID: 2720578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy and safety of once-daily dosing of a novel, prolonged-release oral morphine tablet compared with twice-daily dosing of a standard controlled-release morphine tablet in patients with cancer pain: a randomized, double-blind, exploratory crossover study.
    Ridgway D; Sopata M; Burneckis A; Jespersen L; Andersen C
    J Pain Symptom Manage; 2010 Apr; 39(4):712-20. PubMed ID: 20413058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of 2 sustained-release morphine preparations for pain in advanced cancer.
    Homsi J; Walsh D; Lasheen W; Nelson KA; Rybicki LA; Bast J; LeGrand SB
    Am J Hosp Palliat Care; 2010 Mar; 27(2):99-105. PubMed ID: 19776372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized, double-blind, cross-over trial comparing safety and efficacy of oral controlled-release oxycodone with controlled-release morphine in patients with cancer pain.
    Bruera E; Belzile M; Pituskin E; Fainsinger R; Darke A; Harsanyi Z; Babul N; Ford I
    J Clin Oncol; 1998 Oct; 16(10):3222-9. PubMed ID: 9779695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of transdermal fentanyl and sustained-release oral morphine in patients with cancer and chronic non-cancer pain.
    Clark AJ; Ahmedzai SH; Allan LG; Camacho F; Horbay GL; Richarz U; Simpson K
    Curr Med Res Opin; 2004 Sep; 20(9):1419-28. PubMed ID: 15383190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of severe pain with sustained-release morphine tablets v. oral morphine solution.
    Arkinstall WW; Goughnour BR; White JA; Stewart JH
    CMAJ; 1989 Mar; 140(6):653-7, 661. PubMed ID: 2645988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and clinical efficacy of oral morphine solution and controlled-release morphine tablets in cancer patients.
    Thirlwell MP; Sloan PA; Maroun JA; Boos GJ; Besner JG; Stewart JH; Mount BM
    Cancer; 1989 Jun; 63(11 Suppl):2275-83. PubMed ID: 2720576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative clinical efficacy and safety of immediate release and controlled release hydromorphone for chronic severe cancer pain.
    Hays H; Hagen N; Thirlwell M; Dhaliwal H; Babul N; Harsanyi Z; Darke AC
    Cancer; 1994 Sep; 74(6):1808-16. PubMed ID: 7521784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral controlled-release morphine sulfate. Analgesic efficacy and side effects of a 100-mg tablet in cancer pain patients.
    Portenoy RK; Maldonado M; Fitzmartin R; Kaiko RF; Kanner R
    Cancer; 1989 Jun; 63(11 Suppl):2284-8. PubMed ID: 2720577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of sustained release morphine hydrochloride tablets in management of cancer pain: a survey of 567 patients].
    Yu SY; Qiu H; Ma ZS; Chen J; Zhang Y; Chen LZ; Wang DL; Ma ZY
    Zhonghua Yi Xue Za Zhi; 2004 Mar; 84(6):450-5. PubMed ID: 15061959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life and cancer pain: satisfaction and side effects with transdermal fentanyl versus oral morphine.
    Payne R; Mathias SD; Pasta DJ; Wanke LA; Williams R; Mahmoud R
    J Clin Oncol; 1998 Apr; 16(4):1588-93. PubMed ID: 9552070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postoperative intravenous morphine consumption, pain scores, and side effects with perioperative oral controlled-release oxycodone after lumbar discectomy.
    Blumenthal S; Min K; Marquardt M; Borgeat A
    Anesth Analg; 2007 Jul; 105(1):233-7. PubMed ID: 17578980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, double-blind, double-dummy, crossover trial comparing the safety and efficacy of oral sustained-release hydromorphone with immediate-release hydromorphone in patients with cancer pain. Canadian Palliative Care Clinical Trials Group.
    Bruera E; Sloan P; Mount B; Scott J; Suarez-Almazor M
    J Clin Oncol; 1996 May; 14(5):1713-7. PubMed ID: 8622092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methadone versus morphine as a first-line strong opioid for cancer pain: a randomized, double-blind study.
    Bruera E; Palmer JL; Bosnjak S; Rico MA; Moyano J; Sweeney C; Strasser F; Willey J; Bertolino M; Mathias C; Spruyt O; Fisch MJ
    J Clin Oncol; 2004 Jan; 22(1):185-92. PubMed ID: 14701781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of TTS-fentanyl with sustained-release oral morphine in the treatment of patients not using opioids for mild-to-moderate pain.
    van Seventer R; Smit JM; Schipper RM; Wicks MA; Zuurmond WW
    Curr Med Res Opin; 2003; 19(6):457-69. PubMed ID: 14594516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of a once-a-day sustained-release morphine formulation with standard oral morphine treatment for cancer pain.
    Broomhead A; Kerr R; Tester W; O'Meara P; Maccarrone C; Bowles R; Hodsman P
    J Pain Symptom Manage; 1997 Aug; 14(2):63-73. PubMed ID: 9262035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.